Multiple-drug involvement in overdose deaths has risen in NC
October 14, 2021 Between 2015 and 2019, North Carolina saw an increase in overdose deaths that involved multiple drugs, highlighting the rapidly changing nature of drug overdoses in the state.
Dr. Beth Moracco honored with 2021 Edward Graham Kidder Faculty Service Award
October 12, 2021 The Edward Kidder Graham Award recognizes distinguished service by a UNC-Chapel Hill faculty member that benefits the University, North Carolina and the United States. The 2021 award was presented to Dr. Beth Moracco, associate professor of health behavior at the UNC Gillings School of Global Public Health and associate director of the UNC Injury Prevention Research Center.
Dr. Ralph Baric receives O. Max Gardner Award for coronavirus research
October 12, 2021 UNC-Chapel Hill professor Dr. Ralph Baric — a world renowned coronavirus expert — has contributed to the development of life-saving vaccines and pharmaceutical treatments during the COVID-19 pandemic.
UNC awarded $11.7 million to help providers improve HPV vaccine communication, uptake among adolescents
October 6, 2021 Provider recommendations are key to increasing HPV vaccination rates. A new $11.7 million research initiative, led by UNC Gillings researchers, will equip health care providers with the support necessary to communicate about HPV vaccines more effectively.
$1 million gift furthers landmark study focused on reducing breast cancer disparities, barriers to high-quality care
October 5, 2021 Rich Preyer and Marilyn Jacobs Preyer have donated $1 million to support the latest phase of the Carolina Breast Cancer Study at the UNC Lineberger Comprehensive Cancer Center. Led by Dr. Melissa Troester, professor of epidemiology at the UNC Gillings School, the study investigates how the causes, treatments and long-term outcomes of breast cancer differ between Black women and white women.
Carolina research produces effective experimental pill to treat COVID-19
October 1, 2021 University of North Carolina at Chapel Hill research set the stage to seek emergency authorization of the first oral antiviral drug to treat COVID-19.
Gillings students propose framework for addressing health disparities in US maternal mortality
October 1, 2021 Five students in the Population Health for Clinicians concentration collaborated on a publication that creates a model for understanding and addressing determinants that contribute to maternal mortality in the United States.
Communicating for Health Impact Lab to build upon UNC legacy of health communication work
September 30, 2021 Good health communication translates hard science into plain language. Showing people what to expect from their behaviors ultimately saves lives.
UNC-Chapel Hill Peer Support Core reflects on impact of inaugural year
September 30, 2021 September marks the one-year anniversary of the launch of the UNC-Chapel Hill Peer Support Core, an organization charged with “increasing resources for programs focused on peer-to-peer support, non-crisis support and discussion.” In honor of this milestone, the Peer Support Core has released its 2020-2021 Annual Report, which highlights the impact made on mental health and wellness.
UNC researchers awarded $9.25 million to study DNA variance related to disease
September 30, 2021 Dr. Michael Love, assistant professor of biostatistics at the Gillings School, is a co-investigator on a new five-year project — part of the $185 million Impact of Genomic Variation on Function Consortium, which is funded by the National Institutes of Health.